INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS BONE LOSS IN CORTICOSTEROID-TREATED PATIENTS AND REDUCES FRACTURE RATE IN A SUBGROUPOF POSTMENOPAUSAL WOMEN
Jd. Adachi et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS BONE LOSS IN CORTICOSTEROID-TREATED PATIENTS AND REDUCES FRACTURE RATE IN A SUBGROUPOF POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 267-267